Johnson & Johnson Vision (JJV) announced Acuvue Oasys with Transitions Light Intelligent Technology, a contact lens that provides wearers with vision correction and a dynamic photochromic filter that helps to continuously balance the amount of light entering the eye. These contact lenses quickly and seamlessly adjust from clear to dark to help the human eye manage different types of light and varying intensities of brightness throughout the day, according to the company.

Acuvue Oasys with Transitions has received 510(k) clearance from the U.S. Food and Drug Administration and is indicated for the attenuation of bright light. The two-week reusable, spherical lens will be marketed by Johnson & Johnson Vision Care, Inc. and will be commercially available in the first half of 2019. The lenses were developed through a strategic partnership between Johnson & Johnson Vision and Transitions Optical. ■


Morton “Mort” Kenneth Greenspoon, OD, passed away on Apr. 2, 2018 at the age of 89. After graduating from the Southern California College of Optometry in 1951, Dr. Greenspoon opened his own practice that same year in Sherman Oaks, CA (now known as Professional VisionCare Associates) and saw patients up to a week before his death.

He took over his father’s special cosmetic contact lens practice in the early 1950s and was later the first optometrist to receive a movie credit for his work on “The Lost Boys” in 1987. Notable celebrities for whom he provided lenses include Elvis Presley in “Flaming Star,” Audrey Hepburn in “Wait Until Dark,” Yul Brenner in “Westworld,” Bill Bixby in “The Incredible Hulk,” and Michael Jackson in “Thriller,” among others. He is also known for fitting the first mirrored contact lens for “Camelot.”

He is survived by his wife Sandra and his three daughters Claudia Mosher, Ronda Carnegie, and Andrea Medina as well as six grandchildren and two great-grandchildren. ■


The goal of Contact Lens Spectrum is to provide you with timely and thought-provoking articles that will help you become a more successful contact lens practitioner. Please let us know how we’re doing! E-mail with your comments or article submissions.


BostonSight appointed Daniel C. Brocks, MD, as the full-time chief medical officer. Dr. Brocks will oversee delivery of BostonSight treatment solutions to patients suffering from diseases of the ocular surface.

Dr. Brocks is a board-certified ophthalmologist with a specialization in the medical and surgical treatment of the cornea. He specializes in the treatment of dry eye disease and is the founder of The Dry Eye Center at Hudson Valley Eye Surgeons in Fishkill, NY.

His interest is in the treatment of dry eye related to various autoimmune issues including Sjögren’s syndrome. He also specializes in the management of corneal disorders with a specific interest in the management of infectious keratitis, corneal ectasia, and rheumatologic associated with corneal and anterior segment disorders.

He is a member of the American Academy of Ophthalmology, the International Society of Refractive Surgery, The Corneal Society, The Sjögren’s Syndrome Foundation, the American Association for Physician Leadership, the American Telemedicine Association, the Refractive Surgery Alliance, the Scleral Lens Education Society, the Association for Research in Vision and Ophthalmology, and the Contact Lens Association of Ophthalmologists. ■


Thomas Aller, OD, has launched an educational and informational website, . The clinically reviewed resource will feature the latest data highlights from research and peer-reviewed journals on leading-edge therapies for myopia, with a focus on evidence-based clinical data, practical treatment options, and hands-on management strategies.

Dr. Aller, who has been conducting myopia control research for more than 25 years, is the clinical content editor and curator for the site. He holds several patents in the field of myopia and has collaborated with leading myopia researchers. He is a visiting scholar at the University of California, Berkeley School of Optometry as well as an adjunct professor, University of Houston College of Optometry. Dr. Aller is also on the Clinical Guidelines Committee for the International Myopia Institute, a scientific, clinical advisor for TreeHouse Eyes, and is on the advisory board for Visioneering Technologies, Inc.

The website is made possible by an unrestricted educational grant from Visioneering Technologies, Inc. ■


The American Academy of Optometry announced the recipients of the 2018 Student Travel Fellowship Awards, which will allow six students to present their research at the Association for Research in Vision and Ophthalmology (ARVO) 2018 annual meeting. Following are the 2018 recipients and their respective schools.

Supported by Johnson and Johnson, The Vision Care Institute, LLC:

  • Jessica Jasien, University of Alabama at Birmingham (UAB) School of Optometry
  • Daisy Shu, BOptom(Hons)/BSci, University of New South Wales School of Optometry and Vision Science
  • Laura Pardon, OD, MS, University of Houston College of Optometry
  • Katie Bales, UAB School of Optometry
  • Hannah Burfield, University of Houston College of Optometry

Supported by the American Academy of Optometry:

  • Billie Beckwith-Cohen, DVM, MBA, University of California, Berkeley School of Optometry

The Academy administers travel fellowships to encourage optometry students, optometric residents, and students in eye- and vision-related graduate programs to attend key national meetings and exchange scientific ideas on research.

These fellowships are awarded primarily for accomplishment and potential in optometric research and education and are evaluated by the Academy’s Research Committee.

Applications for student travel fellowships for the Academy’s annual meeting, Academy 2018 San Antonio, will be available in July 2018. For more information, visit . ■


Seed Co. Ltd. announced the acquisition of Contact Lens Precision Laboratories Ltd. (CLPL). As of Apr. 9, 2018, CLPL is now a wholly owned subsidiary of Seed.

CLPL produces specialty and custom lenses that are sold in more than 40 counties, and the company has manufactured and marketed contact lenses for more than 50 years from the United Kingdom under the UltraVision and Kerasoft brand names.

Seed has plans to develop higher-quality contact lenses by using CLPL’s advanced design and optical analysis technology, according to the company. It also intends to expand its contact lens sales in the United Kingdom and Ireland.

CLPL further plans to use Seed’s skills and specific knowledge on the mass production of frequent replacement contact lenses in the specialized soft lens industry. CLPL says it will be able to expand its specialty lens manufacturing while applying greater price competitiveness. CLPL will also take advantage of Seed’s marketing network, especially in Asia.

Diane Angell and John Clamp, joint CEOs of CLPL and UltraVision, respectively, will continue in this position after CLPL becomes a subsidiary of Seed. Seed will in turn send a number of non-executive directors to CLPL and UltraVision and exchange junior engineers with UltraVision. ■


ABB Optical Group released market data showing that eyecare practices that ship more than 10% of their soft contact lens (SCL) sales directly to patients outpace the national average for dollar growth. Conversely, practices with little to no direct-to-patient shipping activity underperform compared to the national average. The national average for direct-to-patient dollar share was 25%, and the national average for dollar growth in 2017 was 7.2%. Practices with more than 45% direct-to-patient dollar share grew 8.6% year-over-year, while practices with less than 10% direct-to-patient dollar share grew at only 6.3%.

ABB Optical’s data also indicate that more than one-third of direct-to-patient shipments are daily disposables and that more than one-quarter of direct-to-patient shipments are torics.

The analysis is based on 2017 sales data from approximately 11,000 eyecare offices, which represents nearly 31% of total contact lens wholesale dollars in the United States. ■


An update to Brien Holden Vision Institute (BHVI)’s free web-based Myopia Calculator has added features that include an “ethnicity” option, and it is now also available in Mandarin and Spanish.

The added “ethnicity” option now enables users to switch between “Asian” and “Caucasian.” The estimated annual progression is calculated using data from the BHVI database (for Asian ethnicities) and published meta-analysis (for Caucasian ethnicity).

The Myopia Calculator can be used to estimate the annual progression of myopia with and without management using age, refractive error at presentation, and ethnicity. To access the calculator, visit . This latest version requires users to complete a one-off registration to obtain access. ■


IDOC is launching a “Satisfaction Guarantee” program that allows independent ODs to take full advantage of an IDOC membership program risk-free. If members are not completely satisfied with their IDOC membership, their dues will be refunded in full if all conditions of the offer are met.

In an unrelated announcement, IDOC is expanding and introducing a new IDOC Select Contact Lens Plan. IDOC members will have access to a new IDOC Select Contact Lens Plan in addition to the current IDOC Select Contact Lens and Lab Plan offering. As with the existing plan, Alcon and CooperVision continue as exclusive manufacturers to IDOC Select. ■


The American Optometric Association (AOA) and Optometry Cares-The AOA Foundation have announced this year’s selections for induction into the National Optometry Hall of Fame. Since 1998, the National Optometry Hall of Fame has recognized doctors of optometry who have made significant and long-lasting contributions to the optometric profession. The inductees will be honored at a ceremony during Optometry’s Meeting in Denver. The 2018 inductees are David A. Cockrell, OD; Lesley L. Walls, OD; and Irwin Suchoff, OD. For more information about this year’s inductees, visit .

In other AOA news, the 2018 Award winners will be recognized at the 2018 Optometry’s Meeting Opening General Session. The Optometrist of the Year Award recognizes David Redman, OD, for his outstanding service on behalf of the profession and the visual welfare of the public. The Young Optometrist of the Year Award recognizes Matthew Jones, OD, who has been in practice less than 10 years and demonstrates remarkable leadership when serving the profession, patients, and his community. The Paraoptometric of the Year Award recognizes Carol Lovell, CPOT, CPOC, for her significant contributions to the profession of paraoptometry. The Optometric Educator Award recognizes Mark Swanson, OD, for outstanding service on behalf of the profession, optometric education, and the visual welfare of the public. The Distinguished Service Award recognizes Joseph Mallinger, OD, for his unusually significant contributions to the profession of optometry. ■


  • EyeGate Pharmaceuticals, Inc. announced that the United States Patent and Trademark Office (USPTO) has issued the company a patent covering the utility of its iontophoretic contact lens. This first-of-its-kind patent relates to a multi-layer contact lens for ocular therapy, comprising a reservoir adapted to contain an electrically-charged therapeutic compound and an electrode providing iontophoretic current to the charged compound to propel it into the ocular tissue. The iontophoretic contact lens provides an easy, potentially improved technique for delivery of therapeutics to the retina, according to Eyegate.
  • Avedro, Inc. announced that James F. Schuermann has joined the company as chief business officer (CBO). Mr. Schuermann will lead the global government affairs, health economics and reimbursement, communications, sales, field service, marketing, and business development functions and will report to Avedro’s CEO, Reza Zadno. In his new role, Mr. Schuermann will oversee the expanded commercialization of Avedro’s cross-linking drugs and devices, including the expansion of sales territories and reimbursement supporting the United States and continued expansion in key international markets in Europe and Asia. He brings more than 20 years of global medical device experience and joins Avedro from Medtronic, where he served as vice president and general manager of Mechanical Circulatory Support. In other news, Avedro announced that it has reached a milestone, celebrating 10 years of scientific research, innovation, and business.
  • SynergEyes, Inc. announced the appointments of Jessica Chi and Mark Hinds to the Professional Relations team for SynergEyes in Australia/New Zealand. Dr. Chi is the director of Eyetech Optometrists, an independent specialty contact lens practice in Melbourne. She is the current vice president of the Cornea and Contact Lens Society of Australia (CCLSA) and previously served as national president of the CCLSA. She is a clinical supervisor at the University of Melbourne, a member of the Victoria Optometric Sector Advisory Group, and a columnist for MiVision. Dr. Chi is a fellow of the Australian College of Optometry and the British Contact Lens Association (BCLA). She consults for various contact lens companies and is an invited speaker throughout Australia and beyond. Dr. Hinds has been involved with Queensland University of Technology School of Optometry post-graduate specialty contact lens clinics since 2004 and lectures to the fourth-year students in their advanced contact lens studies. He has a private practice in Brisbane (Queensland, Australia) with a clinical focus on specialty contact lenses for the complex cornea. He is also a fellow of the BCLA.
  • Kentucky Gov. Matt Bevin signed into law House Bill 191, the Consumer Protection in Eye Care Act. The bill, which passed both the House and Senate with widespread, bipartisan support, allows consumers to use advancements in eyecare technology while also establishing safety standards to protect consumer health. The law also protects current and future opportunities to utilize telehealth. Optometrists and ophthalmologists supported the legislation in its final version. Safeguards include a minimum age of 18 to use the technology, a prior in-person eye examination within the previous 24 months, the same standard of care applied as when conducted in an in-person visit, and the technology cannot be utilized for an initial contact lens prescription.
  • Opternative has launched EZRx, a software solution that enables eyecare practitioners (ECPs) to include digital refractions and visual acuity tests on their websites. According to the company, EZRx, powered by Opternative, helps ECPs increase revenue, retain current patients, and deliver new patients through referral channels and increased access points. Opternative’s partnership with ECPs is a result of recommendations made by the company’s Medical Advisory Board and optometric advisers.
  • The International Association of Contact Lens Educators (IACLE) has secured ongoing funding for its activities in 2018, thanks to the generous support of industry partners. For 2018, Alcon has once again committed to supporting IACLE at the Platinum level. Alcon is joined by Gold Sponsor CooperVision, Silver Sponsor Johnson & Johnson Vision, Bronze Sponsor Bausch + Lomb, and Donor Sponsor Euclid in continuing to support IACLE’s mission. In-kind sponsors are the Centre for Ocular Research & Education (CORE) and the Association of Optometric Contact Lens Educators (AOCLE).
  • I-MED Pharma Inc. received regulatory approval from INVIMA in Colombia and ANMAT in Argentina for its patented I-PEN Osmolarity System, which is a handheld platform that offers eyecare professionals a tool for screening dry eye patients. ■